Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
| Autor: | Ilg, Marcus M., Stafford, Simon J., Mateus, Marta, Bustin, Stephen A., Carpenter, Michael J., Muneer, Asif, Bivalacqua, Trinity J., Ralph, David J., Cellek, Selim |
|---|---|
| Zdroj: | In The Journal of Sexual Medicine October 2020 17(10):1848-1864 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|